tiprankstipranks
Lexeo Therapeutics, Inc. (LXEO)
NASDAQ:LXEO
US Market
LXEO
Lexeo Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see LXEO full AI Analyst Report?

Lexeo Therapeutics, Inc. (LXEO) Income Statement

291 Followers

Lexeo Therapeutics, Inc. Income Statement

Last quarter (Q4 2025), Lexeo Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Lexeo Therapeutics, Inc.'s net income was $-20.92M. See Lexeo Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 654.00K$ 1.66M
Gross Profit
$ 0.00$ 0.00$ 0.00$ 654.00K$ 1.66M
Operating Expenses
$ 109.26M$ 105.77M$ 68.51M$ 61.16M$ 52.29M
Depreciation and Amortization
$ 2.08M$ 2.00M$ 1.84M$ 1.15M$ 13.00K
EBITDA
$ -97.68M$ -96.19M$ -64.35M$ -58.04M$ -50.61M
Operating Income
$ -109.26M$ -105.77M$ -68.51M$ -60.51M$ -50.64M
Other Income/Expenses
$ 9.30M$ 7.43M$ 2.12M$ 1.23M$ 15.00K
Pretax Income
$ -99.96M$ -98.33M$ -66.39M$ -59.28M$ -50.62M
Net Income
$ -99.96M$ -98.33M$ -66.39M$ -59.28M$ -50.62M
Per Share Metrics
Basic EPS
$ -1.86$ -3.09$ -2.49$ -2.36$ -2.01
Diluted EPS
$ -1.86$ -3.09$ -2.49$ -2.40$ -2.01
Weighted Average Shares Outstanding
 53.65M 31.79M 26.65M 25.17M 25.17M
Weighted Average Shares Outstanding (Diluted)
 53.65M 31.79M 26.65M 25.17M 25.17M
Currency in USD

Lexeo Therapeutics, Inc. Earnings and Revenue History